United Guardian (UG) Cash from Investing Activities (2010 - 2026)
United Guardian's (UG) quarterly Cash from Investing Activities came in at $134889.0 in Q2 2026, down 34.62% year-over-year from $206316.0 in Q2 2025, and up 347.94% quarter-over-quarter from $30113.0 in Q1 2026.
Analysis
United Guardian (UG) Cash from Investing Activities (2010 - 2026) Analysis & Trends
United Guardian has disclosed Cash from Investing Activities across 17 years of filings, most recently posting $134889.0 for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 34.62% year-over-year to $134889.0; the TTM figure through Jun 2026 stood at -$545341.0 (up 90.15% YoY), while the FY2025 annual figure was $175343.0, up 102.48% from the prior year.
- Cash from Investing Activities came in at $134889.0 for Q2 2026 at United Guardian, up from $30113.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $4.8 million in Q2 2023 to a low of -$5.6 million in Q3 2024.
- Average Cash from Investing Activities over 5 years is -$61772.8, with a median of $3683.0 recorded in 2023.
- Year-over-year, Cash from Investing Activities plunged 144210.54% in 2024 and soared 2496.8% in 2025.
- Over 5 years, Cash from Investing Activities stood at $1.1 million in 2022, then slumped by 100.05% to -$579.0 in 2023, then sank by 144210.54% to -$835558.0 in 2024, then surged by 107.15% to $59766.0 in 2025, then jumped by 125.7% to $134889.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $134889.0 in Q2 2026, $30113.0 in Q1 2026, and $59766.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | -1.11 Bn |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | -1.20 Bn |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | -5.60 Bn |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | -3.11 Bn |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | 2.11 Bn |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | -424.26 Mn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | -1.66 Bn |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | -51.79 Mn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | 87.50 Mn |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | 134,889.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134,889.00 |
| Mar 31, 2026 | 30,113.00 |
| Dec 31, 2025 | 59,766.00 |
| Sep 30, 2025 | -770,109.00 |
| Jun 30, 2025 | 206,316.00 |
| Mar 31, 2025 | 679,370.00 |
| Dec 31, 2024 | -835,558.00 |
| Sep 30, 2024 | -5.58 Mn |
| Jun 30, 2024 | 7,945.00 |
| Mar 31, 2024 | -665,478.00 |
| Dec 31, 2023 | -579.00 |
| Sep 30, 2023 | -72,052.00 |
| Jun 30, 2023 | 4.85 Mn |
| Mar 31, 2023 | -46,088.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | -594,901.00 |
| Jun 30, 2022 | 406,278.00 |
| Mar 31, 2022 | -47,128.00 |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | -1.08 Mn |